Incyte (INCY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY)

INCY 104.18

+0.1%

Nov 17 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: software salesperson	11/23/2011 10:34:13 AM
	Read Replies (2) of 3202

Since mcbio , Dew and pgs were discussing jak1 vs jak2 on ihub, here is the most relevant info that I could find that (obliquely?) compares incy’s 050 to glpg’s 0634. Looks to me that the difference between them re: jak1/jak2 is not absolute, instead being one of degree rather than kind. Bwdik. Now, if someone could provide the relevant analysis…… Results: INCB028050 was identified as structurally unique orally bioavailable JAK1/JAK2 inhibitor with nanomolar potency against JAK1 (1.1 nM) and JAK2 (0.3 nM). incyte.com vs. http://pulse.companywebcast.nl/playerv1_0/default.aspx?id=16993&bb=true&swf=true sales

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next